122 related articles for article (PubMed ID: 19030000)
1. Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia.
Vilayur E; Trevillian P; Walsh M
Nat Clin Pract Nephrol; 2009 Jan; 5(1):54-8. PubMed ID: 19030000
[TBL] [Abstract][Full Text] [Related]
2. Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.
Mutluay R; Aki SZ; Erten Y; Konca C; Yagci M; Barit G; Sindel S
Clin Nephrol; 2008 Dec; 70(6):527-31. PubMed ID: 19049712
[TBL] [Abstract][Full Text] [Related]
3. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features.
Bridoux F; Hugue V; Coldefy O; Goujon JM; Bauwens M; Sechet A; Preud'Homme JL; Touchard G
Kidney Int; 2002 Nov; 62(5):1764-75. PubMed ID: 12371978
[TBL] [Abstract][Full Text] [Related]
4. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
[TBL] [Abstract][Full Text] [Related]
5. Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.
Bartel C; Obermüller N; Rummel MJ; Geiger H; Hauser IA
Clin Nephrol; 2008 Apr; 69(4):285-9. PubMed ID: 18397703
[TBL] [Abstract][Full Text] [Related]
6. Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy.
Javaugue V; Dufour-Nourigat L; Desport E; Sibille A; Moulin B; Bataille P; Bindi P; Garrouste C; Mariat C; Karlin L; Nouvier M; Goujon JM; Gnemmi V; Fermand JP; Touchard G; Bridoux F
Kidney Int; 2021 Feb; 99(2):421-430. PubMed ID: 32739419
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy-associated proliferative glomerulonephritis.
Sethi S; Rajkumar SV
Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
[TBL] [Abstract][Full Text] [Related]
8. Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis.
Pandrangi S; Singh A; Wheeler DE; Rossi NF
Nat Clin Pract Nephrol; 2008 Jul; 4(7):393-7. PubMed ID: 18493239
[TBL] [Abstract][Full Text] [Related]
9. Molecular study of an IgG1kappa cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia.
Galea HR; Bridoux F; Aldigier JC; Paraf F; Bordessoule D; Touchard G; Cogné M
Clin Exp Immunol; 2002 Jul; 129(1):113-8. PubMed ID: 12100030
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for polyneuropathy with IgM monoclonal gammopathy.
Niermeijer JM; Eurelings M; Lokhorst HL; van der Pol WL; Franssen H; Wokke JH; Notermans NC
J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):1036-9. PubMed ID: 19684235
[TBL] [Abstract][Full Text] [Related]
11. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
Aleem A
Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
[No Abstract] [Full Text] [Related]
12. Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia.
Oo TH
South Med J; 2005 Dec; 98(12):1227-8. PubMed ID: 16440930
[No Abstract] [Full Text] [Related]
13. Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution.
Bitzan M; Ouahed JD; Krishnamoorthy P; Bernard C
Pediatr Nephrol; 2008 Aug; 23(8):1355-61. PubMed ID: 18351394
[TBL] [Abstract][Full Text] [Related]
14. Rituximab treatment of fibrillary glomerulonephritis.
Collins M; Navaneethan SD; Chung M; Sloand J; Goldman B; Appel G; Rovin BH
Am J Kidney Dis; 2008 Dec; 52(6):1158-62. PubMed ID: 18823685
[TBL] [Abstract][Full Text] [Related]
15. Successful use of rituximab in fibrillary glomerulopathy.
Chaudhary A; Gyamlani G; Cossey NL; Walker PD; Wall BM
Ren Fail; 2014 Aug; 36(7):1151-4. PubMed ID: 24831880
[TBL] [Abstract][Full Text] [Related]
16. A case of immunotactoid glomerulopathy with unusual microtubular deposits.
Mukai K; Kitazawa K; Totsuka D; Saito K; Sugisaki T
Clin Nephrol; 1998 May; 49(5):321-4. PubMed ID: 9617498
[TBL] [Abstract][Full Text] [Related]
17. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome.
Seipelt G; Böhme A; Koschmieder S; Hoelzer D
Ann Hematol; 2001 Mar; 80(3):170-3. PubMed ID: 11320903
[TBL] [Abstract][Full Text] [Related]
19. Membranous glomerulonephritis in chronic lymphocytic leukemia.
Ziakas PD; Giannouli S; Psimenou E; Nakopoulou L; Voulgarelis M
Am J Hematol; 2004 Jul; 76(3):271-4. PubMed ID: 15224365
[TBL] [Abstract][Full Text] [Related]
20. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.
Ravindran A; Fervenza FC; Smith RJH; Sethi S
Kidney Int; 2018 Jul; 94(1):178-186. PubMed ID: 29729982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
